)
Dis-Chem Pharmacies (DCP) investor relations material
Dis-Chem Pharmacies H1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
H1 revenue rose 8.0% to R22,974m and total income increased 9.0% to R7,204m; operating profit fell 10.5% to R1,006m.
Better Rewards and retail market-share gains supported trading, while constrained consumer spending, price deflation and higher costs weighed on earnings.
Basic EPS declined 13.3% to 64.1 cents and HEPS fell 12.8% to 64.3 cents.
Financial highlights
Profit before tax fell 13.0% to R783.3m; net profit declined 12.0% to R580.6m.
Net finance costs increased 11.2% to R275m; excluding IFRS 16 finance costs, they rose 13.3%.
Total income margin improved to 31.4% from 31.1%.
Interim dividend declared was 25.62181 cents per share, down 12.9% YoY and equal to 40% of headline earnings.
Outlook and guidance
Revenue grew 7.9% in the seven weeks to 19 October 2026; retail revenue rose 7.2% and external wholesale revenue increased 12.4%.
FY2027 earnings are expected to be more evenly distributed between H1 and H2, with a stronger full-year earnings performance versus the prior year.
Plans include 30 new retail pharmacy stores in FY2027; all new stores will use the Store of the Future format.
Natural inflation is expected to support retail revenue as Better Rewards anniversary base effects unwind; management is focused on cost discipline and rebuilding return on equity.
- Revenue rose 11.1%; H2 pretax earnings rebounded 22% despite lower reported EPS.DCP
H2 2024 - Better Rewards and Store of the Future drove revenue growth and market share gains amid restructuring.DCP
AGM 2026 - Revenue up 9.3% and core retail profit before tax up 27.1%, driven by Better Rewards and innovation.DCP
H2 2026 - Revenue up 8.7%, core retail profit before tax up 25.8%, and dividend up 9.0%.DCP
H1 2026 - Revenue and profit rose strongly, supported by cost control and strategic investments.DCP
H1 2025 - Revenue up 8.0% and operating profit up 18.3% on property rollout and wholesale share gains.DCP
H2 2025
Next Dis-Chem Pharmacies earnings date
Next Dis-Chem Pharmacies earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)